ADT for advanced prostate cancer increases risk of bone fractures, says new study

Androgen deprivation therapy (ADT), used to treat prostate cancer, has a significant association with increasing a man’s risk for bone fractures, according to a large population-based study published in PLOS ONE. More than 13,000 men, with a mean age of 74.4 and newly diagnosed with prostate cancer, were included in this study from the Taiwan National Health Insurance Research Database.